Clinical practice guideline on bladder cancer (Part I)

  • Dong X
  • Song G
  • Guan K
  • et al.
N/ACitations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Bladder cancer represents one of the most prevalent malignant tumors affecting the urinary system. As per data disclosed by the National Cancer Registration Center of China in 2019, the incidence of bladder cancer was 5.80 per 100,000 in 2015, placing it as the thirteenth most common systemic malignancy. Bladder cancer poses a substantial threat to public health in China, underlining the critical importance of standardizing diagnosis and treatment to enhance clinical outcomes. This clinical practice guideline for bladder cancer centers on the etiologies, clinical presentations, and diagnostic procedures for suspected bladder cancer, in addition to the histopathology and staging of urothelial bladder cancer.

Cite

CITATION STYLE

APA

Dong, X., Song, G., Guan, K., Wang, T., Feng, X., Liu, Y., … Xing, N. (2023). Clinical practice guideline on bladder cancer (Part I). UroPrecision, 1(1), 20–30. https://doi.org/10.1002/uro2.11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free